These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2143879)

  • 1. [The mono-oxygenase enzyme system of the liver in patients with true eczema].
    Ashirmetov AKh; Akovbian VA; Krakovskiĭ ME; Tikhonova NN
    Vestn Dermatol Venerol; 1990; (4):46-9. PubMed ID: 2143879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatic blood flow and the liver mono-oxygenase system in patients with ischemic heart disease].
    Khakimov ZZ; Azizov KN; Iuldasheva FI; Rakhmanov AKh
    Eksp Klin Farmakol; 1995; 58(3):32-3. PubMed ID: 7663292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The function of the monooxygenase system of the liver in patients with psoriasis].
    Chichenina IV
    Vestn Dermatol Venerol; 1989; (8):32-5. PubMed ID: 2816028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The mono-oxygenase enzyme system of the liver in patients with viral hepatitis A and B].
    Musabaev EI; Krakovskiĭ ME; Ashirmetov AKh
    Klin Med (Mosk); 1987 Sep; 65(9):79-82. PubMed ID: 3695318
    [No Abstract]   [Full Text] [Related]  

  • 5. [The antipyrine test in occupational medicine research--evaluation of individual reproducibility and frequency distribution of half-life].
    Uhlig H; Damrau J; Skölziger R
    Z Gesamte Hyg; 1989 Feb; 35(2):82-4. PubMed ID: 2741499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of antipyrine for assessing the enzymatic activity of the liver monooxygenase system (a review of the literature)].
    Ashirmetov AKh; Krakovskiĭ ME
    Lab Delo; 1990; (1):16-20. PubMed ID: 1691329
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiopyrine half-life as a measure of hepatic enzyme induction: clinical applications in a chronic epileptic population.
    Byrne E; Harman AW; Frewin DB; Hallpike JF
    Clin Exp Neurol; 1979; 16():183-9. PubMed ID: 550940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative investigation of antipyrine half-life and induction of cytochrome P-450 dependent monooxygenases in rats treated with phenylurea herbicides.
    Schoket B; Zilahy Z; Molnar J; Vincze I
    In Vivo; 1987; 1(3):185-7. PubMed ID: 2979785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations between cytochrome P-450 and oxidative metabolism of benzo[a]pyrene and 7-ethoxycoumarin in human liver in vitro and antipyrine elimination in vivo.
    Pelkonen O; Sotaniemi E; Tokola O; Ahokas JT
    Drug Metab Dispos; 1980; 8(4):218-22. PubMed ID: 6105054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of alpha methyldopa on the mixed oxygenase system of the liver in man].
    Gachályi B; Tornyossy M; Vas A; Káldor A
    Orv Hetil; 1979 Apr; 120(15):897-8. PubMed ID: 372883
    [No Abstract]   [Full Text] [Related]  

  • 11. [Quantification of the drug-metabolizing enzyme system in liver diseases: a comparison between antipyrine saliva clearance and the aminopyrine breath test].
    von Mandach U; Jost G; Preisig R
    Schweiz Med Wochenschr; 1985 May; 115(19):651-8. PubMed ID: 3923620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipyrine kinetics following tetanus vaccination.
    Descotes J; Simonet R; Evreux JC
    Int J Clin Pharmacol Ther Toxicol; 1986 Nov; 24(11):625-6. PubMed ID: 3793297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics of verapamil and its N-dealkylated metabolites in patients with chronic ischemic heart disease undergoing long-term monotherapy].
    Rumiantsev DO; Piotrovskiĭ VK; Metelitsa VI; Riabokon' OS; Kokurina EV
    Farmakol Toksikol; 1988; 51(1):66-70. PubMed ID: 3360112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interrelation of monooxygenase activity and the function of the immune system in psoriasis patients].
    Khakimov ZZ; Rakhmatov AB; Zalialieva MV; Chichenina IV
    Vestn Dermatol Venerol; 1988; (8):11-3. PubMed ID: 3195202
    [No Abstract]   [Full Text] [Related]  

  • 15. Antipyrine pharmacokinetics in the pregnant rat.
    Dean M; O'Donnell L; Penglis S; Stock B
    Drug Metab Dispos; 1980; 8(4):265-7. PubMed ID: 6105062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The rate of antipyrine metabolism in cancer patients administered specific therapy].
    Bogush TA; Tseĭtlin GIa; Bukhny AF
    Vopr Onkol; 1992; 38(11):1288-93. PubMed ID: 1343156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of metabolic efficiency of the liver in patients with psoriasis by the antipyrine test].
    Bienias L; Czarnecki M; Kaszuba A; Ruszczak Z; Kozłowska M; Bednarowicz G; Drobnik G
    Przegl Dermatol; 1990; 77(5):301-6. PubMed ID: 2270292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma pharmacokinetics of adriamycin and antipyrine and its relation to the therapeutic and toxic effects.
    Preiss R; Matthias M; Sohr R; Brockmann B; Hüller H
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S79-88. PubMed ID: 3842695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Galactose and antipyrine load tests in assessing the detoxification activity of the liver].
    Maestri G; D'Amore V; Angeli E
    Minerva Dietol Gastroenterol; 1979; 25(4):399-406. PubMed ID: 554030
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drug-metabolizing activity of the liver in patients with eczema and allergic dermatitis].
    Zhigulin VA; Smirnova IIu; Bredikhin VT; Filippenko NG
    Vestn Dermatol Venerol; 1989; (3):42-4. PubMed ID: 2741545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.